Literature DB >> 31602590

Gene expression changes and promoter methylation with the combined effects of estradiol and leptin in uterine tissue of the ovariectomized mice model of menopause.

Abhishek Shetty1, Thejaswini Venkatesh2, Rie Tsutsumi3, Padmanaban S Suresh4.   

Abstract

Substantial epidemiological studies have shown an association of obesity with the common gynecological malignancy, endometrial cancer. The relevant interactions and contribution of estradiol and the adipose cytokine, leptin, in endometrial lesions are not completely understood. Suitable animal models to understand the physiological response of uterine tissue to the combined effects of estradiol-leptin are lacking. To investigate the effect of estradiol-leptin crosstalk on gene expression and associated altered pathways, we established an ovariectomized mouse model, treated with 17-β estradiol (0.1 µg/mouse subcutaenously., for every 12 h) and/or recombinant mouse leptin (1 μg/g Bwt intraperitoneally., for every 12 h) for 4 h, 20 h, and 40 h. Gene expressions by semi-quantitative RT-PCR, uterine tissue protein phosphorylation status by western blotting and promoter methylation were analyzed in estradiol, progesterone insufficient animals. Semi-quantitative RT-PCR demonstrated significantly increased expression of Esr, Igf1, Igfbp3, Vegfr1, and Vegf, and significantly decreased expression of Mmp9 after co-treatment with estradiol and leptin, indicating a common transcriptional network regulated by the treatments. Ovariectomy-induced histomorphological changes were only reversed by estradiol. Methylation-specific PCR, analyzing methylation of CpG sites of Vegfa, Pgr, and Igf1, revealed that transcriptional regulation after hormonal treatments is independent of methylation at the examined CpG sites. Western blot confirmed the increased expression of PSTAT-3 (Ser-727) and PERK1/2 proteins after estradiol + leptin treatment, confirming the estradiol + leptin cross-talk hypothesis. In conclusion, our in vivo studies determined specific gene expression and signaling protein changes, and further unraveled the molecular targets of estradiol + leptin that may perturb endometrial homeostasis and lead to endometrial hyperplasia development in the chronic stimulated state.

Entities:  

Keywords:  Endocrine physiology; Hormone response; Uterine tissue

Mesh:

Substances:

Year:  2019        PMID: 31602590     DOI: 10.1007/s11033-019-05116-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  45 in total

1.  Leptin is a metabolic signal to the reproductive system.

Authors:  I A Barash; C C Cheung; D S Weigle; H Ren; E B Kabigting; J L Kuijper; D K Clifton; R A Steiner
Journal:  Endocrinology       Date:  1996-07       Impact factor: 4.736

Review 2.  Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.

Authors:  H Shibata; T E Spencer; S A Oñate; G Jenster; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Recent Prog Horm Res       Date:  1997

3.  Leptin increases VEGF expression and enhances angiogenesis in human chondrosarcoma cells.

Authors:  Wei-Hung Yang; Jui-Chieh Chen; Kai-Hsiang Hsu; Chih-Yang Lin; Shih-Wei Wang; Shoou-Jyi Wang; Yung-Sen Chang; Chih-Hsin Tang
Journal:  Biochim Biophys Acta       Date:  2014-09-16

4.  Biphasic regulation of extracellular-signal-regulated protein kinase by leptin in macrophages: role in regulating STAT3 Ser727 phosphorylation and DNA binding.

Authors:  Lisa O'Rourke; Peter R Shepherd
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

5.  Leptin and body mass index in relation to endometrial cancer risk.

Authors:  Eleni Petridou; Maria Belechri; Nick Dessypris; Panagiotis Koukoulomatis; Emmanuel Diakomanolis; Evangelos Spanos; Dimitrios Trichopoulos
Journal:  Ann Nutr Metab       Date:  2002       Impact factor: 3.374

6.  Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus.

Authors:  Armina A Kazi; Kristin Happ Molitoris; Robert D Koos
Journal:  Biol Reprod       Date:  2009-05-06       Impact factor: 4.285

Review 7.  Biological mechanisms linking obesity and cancer risk: new perspectives.

Authors:  Darren L Roberts; Caroline Dive; Andrew G Renehan
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

8.  Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways.

Authors:  D Sharma; N K Saxena; P M Vertino; F A Anania
Journal:  Endocr Relat Cancer       Date:  2006-06       Impact factor: 5.678

9.  Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells.

Authors:  Jung-Hye Choi; Se-Hyung Park; Peter C K Leung; Kyung-Chul Choi
Journal:  J Clin Endocrinol Metab       Date:  2004-11-02       Impact factor: 5.958

10.  Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity.

Authors:  Ross S Thomas; Naveed Sarwar; Fladia Phoenix; R Charles Coombes; Simak Ali
Journal:  J Mol Endocrinol       Date:  2008-04       Impact factor: 5.098

View more
  1 in total

Review 1.  Role of Leptin and Adiponectin in Endometrial Cancer.

Authors:  Aneta Słabuszewska-Jóźwiak; Aron Lukaszuk; Marta Janicka-Kośnik; Artur Wdowiak; Grzegorz Jakiel
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.